Inhibitors of hepatitis c virus

Patent metadata

Field	Value
Publication number	US-2019008858-A1
Application number	US-201816005111-A
Country	US
Kind code	A1
Filing date	Jun 11, 2018
Priority date	Jul 3, 2012
Publication date	Jan 10, 2019
Grant date	—

Abstract

Compounds of Formula I are disclosed

As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.

First claim

1 .- 84 . (canceled)

85 . A compound of formula:

or a salt thereof.

86 . A compound of formula:

87 . A compound of formula:

88 . A compound of formula:

Assignees

• Gilead Sciences Inc

Inventors

• Bjornson Kyla
• Canales Eda
• Cottell Jeromy J
• Karki Kapil K
• Katana Ashley A
• Kato Darryl
• Kobayashi Tetsuya
• Link John O
• Martinez Ruben
• Phillips Barton W
• Pyun Hyung-Jung
• Sangi Michael
• Schrier Adam J
• Siegel Dustin
• Taylor James G
• Tran Chinh V
• Trejo Martin Teresa A
• Vivian Randall W
• Yang Zheng-Yu
• Zablocki Jeff
• Zipfel Sheila

Classifications

• A61P31/10

  Antimycotics · CPC title

• A61P31/00

  Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• A61P31/12

  Antivirals · CPC title

• A61P31/14

  for RNA viruses · CPC title